68 related articles for article (PubMed ID: 12897987)
21. Role of NAD(P)H oxidase in transforming growth factor-beta1-induced monocyte chemoattractant protein-1 and interleukin-6 expression in rat renal tubular epithelial cells.
Zhang H; Jiang Z; Chang J; Li X; Zhu H; Lan HY; Zhou SF; Yu X
Nephrology (Carlton); 2009 Apr; 14(3):302-10. PubMed ID: 19207862
[TBL] [Abstract][Full Text] [Related]
22. Plasma homocysteine levels in living kidney donors before and after uninephrectomy.
Tsai MY; Aras O; Sozen H; Hanson NQ; Woll PS; Arends VL; Hunninghake DB; Matas AJ
J Lab Clin Med; 2004 Jun; 143(6):340-3. PubMed ID: 15192649
[TBL] [Abstract][Full Text] [Related]
23. [TGF-beta1 in allograft and long-term renal function].
Wang PX; Huang XY; Wang AJ; Huang CB; Fan MQ; Zhang YP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):700-3. PubMed ID: 16114562
[TBL] [Abstract][Full Text] [Related]
24. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
[TBL] [Abstract][Full Text] [Related]
25. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism.
Qi W; Chen X; Zhang Y; Holian J; Mreich E; Gilbert RE; Kelly DJ; Pollock CA
Nephrol Dial Transplant; 2007 Nov; 22(11):3147-53. PubMed ID: 17664181
[TBL] [Abstract][Full Text] [Related]
26. Targeting TGF-beta1 increases hepatocyte growth factor (HGF/SF) levels in external auditory canal cholesteatoma (EACC) epithelial cell culture.
Naim R; Chang RC; Alfano SS; Riedel F; Bayerl C; Sadick H; Bran G; Hormann K
Regul Pept; 2005 Aug; 130(1-2):75-80. PubMed ID: 15913806
[TBL] [Abstract][Full Text] [Related]
27. The bioactivity of transforming growth factor-beta1 can be regulated via binding to dermal collagens in mink lung epithelial cells.
Shibuya H; Okamoto O; Fujiwara S
J Dermatol Sci; 2006 Mar; 41(3):187-95. PubMed ID: 16337361
[TBL] [Abstract][Full Text] [Related]
28. The role of proximal tubular cells in interstitial fibrosis: understanding TGF-beta1.
Phillips A
Chang Gung Med J; 2007; 30(1):2-6. PubMed ID: 17477023
[TBL] [Abstract][Full Text] [Related]
29. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Ventura P; Panini R; Emiliani S; Salvioli G
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
[TBL] [Abstract][Full Text] [Related]
30. TGF-beta1 in chronic allograft nephropathy following renal transplantation.
Harris S; Coupes BM; Roberts SA; Roberts IS; Short CD; Brenchley PE
J Nephrol; 2007; 20(2):177-85. PubMed ID: 17514622
[TBL] [Abstract][Full Text] [Related]
31. Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit.
Carroll JF; Tyagi SC
Am J Hypertens; 2005 May; 18(5 Pt 1):692-8. PubMed ID: 15882553
[TBL] [Abstract][Full Text] [Related]
32. Modulation of ezrin and E-cadherin expression by IL-1beta and TGF-beta1 in human trophoblasts.
Karmakar S; Das C
J Reprod Immunol; 2004 Dec; 64(1-2):9-29. PubMed ID: 15596224
[TBL] [Abstract][Full Text] [Related]
33. Visualisation of transforming growth factor-beta 1, tissue kallikrein, and kinin and transforming growth factor-beta receptors on human clear-cell renal carcinoma cells.
Moodley R; Snyman C; Odhav B; Bhoola KD
Biol Chem; 2005 Apr; 386(4):375-82. PubMed ID: 15899700
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor beta1 release by human adipose tissue is enhanced in obesity.
Fain JN; Tichansky DS; Madan AK
Metabolism; 2005 Nov; 54(11):1546-51. PubMed ID: 16253647
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty.
Kingston PA; Sinha S; Appleby CE; David A; Verakis T; Castro MG; Lowenstein PR; Heagerty AM
Circulation; 2003 Dec; 108(22):2819-25. PubMed ID: 14638551
[TBL] [Abstract][Full Text] [Related]
36. Elevated plasma TGF-beta1 in renal diseases: cause or consequence?
Junker U; Haufe CC; Nuske K; Rebstock K; Steiner T; Wunderlich H; Junker K; Reinhold D
Cytokine; 2000 Jul; 12(7):1084-91. PubMed ID: 10880255
[TBL] [Abstract][Full Text] [Related]
37. Profibrotic cytokines and lymphocyte proliferation in stable renal allograft recipients treated with or without cyclosporine A.
Waiser J; Schneider M; Eljazyfer S; Slowinski T; Glander P; Einecke G; Budde K; Neumayer HH; Böhler T
Clin Immunol; 2006 Apr; 119(1):59-66. PubMed ID: 16451828
[TBL] [Abstract][Full Text] [Related]
38. Atorvastatin treatment in the short term: does it induce renoprotection or vasculoprotection in renal transplantation?
Navarro-Muñoz M; Bonet J; Bayés B; Lauzurica R; Blanco S; Romero R
Transplant Proc; 2007 Sep; 39(7):2259-63. PubMed ID: 17889157
[TBL] [Abstract][Full Text] [Related]
39. TGF-beta1 release by volatile anesthetics mediates protection against renal proximal tubule cell necrosis.
Lee HT; Kim M; Kim J; Kim N; Emala CW
Am J Nephrol; 2007; 27(4):416-24. PubMed ID: 17622749
[TBL] [Abstract][Full Text] [Related]
40. Leukotriene D4-induced, epithelial cell-derived transforming growth factor beta1 in human bronchial smooth muscle cell proliferation.
Bossé Y; Thompson C; McMahon S; Dubois CM; Stankova J; Rola-Pleszczynski M
Clin Exp Allergy; 2008 Jan; 38(1):113-21. PubMed ID: 18028462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
